Real-time systematic review and meta-analysis of non-randomised comparative treatment studies for COVID-19

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/35988
• EU PAS number:
  EUPAS35147
• Study ID:
  35988
• Official title and acronym:
  Real-time systematic review and meta-analysis of non-randomised comparative treatment studies for COVID-19
• DARWIN EU® study:
  No
• Study countries:
  Spain

  United Kingdom
• Study description:
  A real-time systematic review and meta-analysis of non-randomised studies to compare in-hospital clinical outcomes in patients managed with standard care and various treatments for COVID-19.To compare the results of treatments in non-randomised comparative studies and randomised controlled trials for in-hospital clinical outcomes in COVID-19 patients.
• Study status:
  Ongoing

Research institution and networks

Institutions

OXON Epidemiology

Spain

United Kingdom

Study timelines

Date when funding contract was signed

Planned: 08/05/2020

Actual: 08/05/2020

Study start date

Planned: 08/05/2020

Actual: 20/05/2020

Date of final study report

Planned: 10/05/2021

Sources of funding

Other

Pharmaceutical company and other private sector 

More details on funding

GSK, OXON Epidemiology

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable